Dosage Forms

Chris Spivey is director of Industry Relations and Strategic Partnership, MJH Life Sciences.

Articles

Looking at the role that RSV and pediatric medical practices play in drug shortages.

Why We Were Not Properly Winterized for RSV Season

Videos

Chris Spivey, editorial director for Pharmaceutical Technology®, discusses mRNA advances and the background for the leading scientific conference for the field, with host and co-organizer CureVac CEO Dr. Alexander Zehnder. 

mRNA: Unparalleled Potential as a Drug

The new centralized hub will provide advanced testing of nucleic acids, which is expected to simplify mRNA substance testing.

TriLink BioTechnologies Launches Analytical Sciences Center of Excellence

Mike Hennessy Jr. is the President and CEO of 

Industry investments indicate increasing trust in the newest modalities, including mRNA approaches. 

Capitalizing on Success

The final guidance document was issued to assist bio/pharma companies in the clinical development and licensure of COVID-19 vaccines. 

FDA Finalizes Guidance on Development of COVID-19 Vaccines

Felicity Thomas is Associate Editorial Director of Pharmaceutical Technology, Pharmaceutical Technology Europe, BioPharm International.

The companies will co-promote GSK’s shingles vaccine, Shingrix, to healthcare professionals and points of vaccination in China. 

GSK and Zhifei Partner to Extend the Availability of Shingrix

Feliza Mirasol is the science editor for 

Pfizer has entered into a collaboration with Ginkgo Bioworks to discover novel RNA molecules across priority research areas.

Pfizer and Ginkgo Bioworks to Collaborate on Multi-Target RNA Discovery 

European vaccine manufacturing is being boosted with high level investments.  

Booster Shot for Pharma

Podcasts

An mRNA conversation about the recent past, current hot topics, and probable future.

Drug Solutions Podcast: mRNA Past, Present, and Future

Experts discuss the promise of personalized cancer vaccines through the inherent nimbleness of mRNA platform.